ArticleJournal of personalized medicine2024

The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results.

Maria Chiara Lo Greco et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.